Sort
17,828 grants matching “crispr”
Targeting c-Myc stability in c-Myc overexpressing large B-cell lymphoma
$559,179Lapo Alinari · Ohio State University · R01 · FY2023 · CA
Developmental Regulation of Centrosome Duplication
$559,101Kevin O'Connell · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
The role of SERPINB3 in cervical cancer therapeutic resistance
$559,091Stephanie Subasic Markovina · Washington University · R01 · FY2025 · CA
Enhancing the C. elegans animal resource through genome editing
$558,767Ann E. Rougvie · University Of Minnesota · R24 · FY2020 · OD
Multiomic profiling of cell types mediating opioid use disorder in rats
$558,339Francesca Telese · University Of California, San Diego · R01 · FY2025 · DA
Project 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.
$558,338Edward A Stadtmauer · University Of Pennsylvania · P01 · FY2019 · CA
Novel Glaucoma Treatment Using Genome Editing
$558,268Val C Sheffield · University Of Iowa · R01 · FY2014 · EY
RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity
$558,231Patrick Andries Murphy · University Of Connecticut Sch Of Med/Dnt · R01 · FY2022 · HL
A Systems Approach to Mapping the DNA Damage Response
$558,146Trey Ideker · University Of California, San Diego · R01 · FY2020 · ES
Team Science for MultiScale Data Mining and Functional Validation of Single-Cell Opioid Responses in the Context of HIV
$558,085Jing Zhang · University Of California-Irvine · R01 · FY2025 · DA
Multiomic profiling of cell types mediating opioid use disorder in rats
$558,045Francesca Telese · University Of California, San Diego · R01 · FY2023 · DA
Mapping the Pharmacogenetic Landscape for Precision Medicine
$558,043Alan Ashworth · University Of California, San Francisco · U54 · FY2017 · CA
Zebrafish targeted mutagenesis and functional genomics
$557,994Shawn M Burgess · National Human Genome Research Institute · ZIA · FY2021 · HG
Developing Regeneration Resources for a Model Amphibian
$557,910Stephen Randal Voss · University Of Kentucky · R24 · FY2018 · OD
Developing Regeneration Resources for a Model Amphibian
$557,910Stephen Randal Voss · University Of Kentucky · R24 · FY2019 · OD
Identification and characterization of chemical probes of TRIO GEF1 activity
$557,907Anthony J Koleske · Yale University · R01 · FY2025 · MH
A Human-Centered Pharmacogenomic Screen of Metformin Action
$557,729Jose Carlos Florez · Massachusetts General Hospital · R01 · FY2015 · DK
Molecular Targets of Neurosteroid Anti-depressant Action
$557,685Alex S Evers · Washington University · P50 · FY2025 · MH
Molecular Targets of Neurosteroid Anti-depressant Action
$557,685Alex S Evers · Washington University · P50 · FY2023 · MH
Molecular Targets of Neurosteroid Anti-depressant Action
$557,685Alex S Evers · Washington University · P50 · FY2022 · MH
Molecular Targets of Neurosteroid Anti-depressant Action
$557,685Alex S Evers · Washington University · P50 · FY2021 · MH
Molecular Targets of Neurosteroid Anti-depressant Action
$557,685Alex S Evers · Washington University · P50 · FY2024 · MH
Development of novel protein-based therapeutics for lung cancer
$557,605Eric Alejandro Sweet-Cordero · University Of California, San Francisco · R01 · FY2019 · CA
Functional Significance of individual p53 mutations in determining the role of estrogen receptor beta in triple negative breast cancer
$557,448Gokul M Das · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Targeting SMARCA2 in SMARCA4-deficient lung cancers in vivo
$557,418Carla P Concepcion-Crisol · Columbia University Health Sciences · R37 · FY2025 · CA